Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
14 Apr, 2026, 08.08 PM IST
IIT Roorkee inaugurates Ashok Soota Molecular Medicine Facility at BSBE to advance translational biomedical researchIIT Roorkee has launched the Ashok Soota Molecular Medicine Facility, a state-of-the-art platform for advanced biomedical research, drug di...
17 Mar, 2026, 02.27 PM IST
Bengaluru's deep-tech startup proposes 'quantum' leap in cancer careQuantum Biosciences, a Bengaluru startup, is pioneering a quantum biosensor technology for early detection of cellular damage, potentially ...
03 Aug, 2025, 09.24 AM IST
IPO Calendar: 3 new issues eye Rs 3,600 crore as primary market momentum continuesThree IPOs—Anthem Biosciences, Spunweb Nonwoven, and Monika Alcobev—aim to raise over Rs 3,600 crore in the week starting July 14. With str...
13 Jul, 2025, 11.25 AM IST
Absolute raises $100 million in funding led by Sequoia Capital, Alpha Wave, Tiger GlobalLast year, Absolute Foods had raised $2 million from Sequoia Capital’s incubation programme, Surge, and two angel investors: Nadir Godrej a...
05 May, 2022, 09.52 PM IST
Goldman Sachs buys stake in contract research firm Aragen Life SciencesAragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platform...
19 May, 2021, 12.18 PM IST
Goldman Sachs set to buy 33% stake in GVK Bio at Rs 7,300-crore valuationThe other contenders included Carlyle Group, Warburg Pincus, General Atlantic and Quadria Capital, as well as Singapore’s Temasek Holdings.
17 May, 2021, 08.14 AM IST
Tech Mahindra, Reagene to file patent for molecule that potentially attacks coronavirusTech Mahindra Global Head (Makers Lab) Nikhil Malhotra told that the company along with its partner is applying for patenting on which furt...
02 May, 2021, 06.48 PM IST
Anthem Bio catches global buyout funds' eye, stake sale could see valuation rocket to $1 billionLaunched by ex-Biocon executive Ajay Bharadwaj, the Rs 1,200 crore Anthem Biosciences competes with Syngene International and GVK Bio. O3 C...
25 Sep, 2020, 07.20 AM IST
Aurobindo Pharma working on COVID-19 vaccine; shortlisted for BIRAC fundingIn November 2019, Aurobindo Pharma said its subsidiary Auro Vaccines LLC entered into a pact to acquire certain business assets from Profec...
07 Aug, 2020, 11.48 AM IST
Merck sells GeNei back to founderGerman pharmaceutical and life sciences company Merck has sold Bangalore GeNei, a firm that develops products for biological research, back...
08 Apr, 2016, 01.21 AM IST
GVK BIO signs pact with US-based Aragen Bioscience Inc for acquisitionGVK BIO, a leading small-molecule Contract Research Organisation (CRO) today announced that it signed an agreement to acquire Aragen Biosci...
29 Jan, 2014, 05.20 PM IST
GVK Bio, USFDA in drug repositioning collaborationThe company is looking forward to continue working with the FDA with a view to further enhancing the utility of the product, the company sa...
19 Jun, 2013, 04.08 PM IST
- GVK Biosciences, Onconova Therapeutics ink pact to develop cancer drugs
The Hyderabad-based firm and Onconova have entered into a JV to develop new drugs for cancer, GVK Biosciences said in a statement.
09 Jan, 2013, 07.33 PM IST
GVK Biosciences and Onconova Therapeutics to develop new drugs for cancer jointlyThe joint partnership will be based in the US and will align research priorities and tech expertise from both companies.
09 Jan, 2013, 03.42 PM IST
- Frontier Mediville gets India’s first hospital SEZ
The upcoming Frontier Mediville project of Frontier Lifeline at Elavur near Gummidipoondi has been accorded the status of a special economi...
13 Mar, 2009, 08.47 PM IST
- PE player Sequoia invests Rs 100 cr in GVK Bio
Global PE player Sequoia Capital invests Rs 100 cr in Hyderabad-based contract research organisation GVK Biosciences.
27 Nov, 2007, 12.46 AM IST